Characteristics of stem cells from human neuroblastoma cell lines and in tumors

Neoplasia

Volumn 6, Issue 6, 2004, Pages 838-845

  Walton, Jeanette D ^a   Kattan, David R ^a   Thomas, Sharon K ^a   Spengler, Barbara A ^a   Guo, Hong Fen ^b   Biedler, June L ^a   Cheung, Nai Kong V ^b   Ross, Robert A ^a  

^a FORDHAM UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Differentiation; Human neuroblastoma; I type cell; Stem cell; Tumorigenicity

Indexed keywords

AGAR; ENZYME; HERMES ANTIGEN; NEUROTRANSMITTER; VIMENTIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENICITY; CELL CLONE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CYTOPLASM; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; MULTIPOTENT STEM CELL; NEURAL CREST CELL; NEURITE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROFILAMENT; NONHUMAN; NUDE MOUSE; ONCOGENE C MYB; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 4544230424     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04310     Document Type: Article

References (27)

1. Castleberry RP (1997). Biology and treatment of neuroblastoma. Pediatr Clin North Am 44, 919-937.
2. Matthay KK (1997). Neuroblastoma: biology and therapy. Oncology 11, 1857-1866.
3. Brodeur GM (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3, 203-216.
4. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, and Matthay KK (2001). International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors. Cancer 92, 2451-2461.
5. Rettig WJ, Spengler BA, Garin Chesa P, Old LJ, and Biedler JL (1987). Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res 47, 1383-1389.
6. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, and Ross RA (1989). Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49, 219-225.
7. Ross RA, Spengler BA, Domènech C, Porubcin M, Rettig WJ, and Biedler JL (1995). Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6, 449-456.
8. Spengler BA, Lazarova DL, Ross RA, and Biedler JL (1997). Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Oncol Res 9, 467-476.
9. Ross RA, Biedler JL, and Spengler BA (2003). A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors. Cancer Lett 197, 35-39.
10. Reya T, Morrison SJ, Clarke MF, and Weissman IL (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111.
11. Valent A, Bénard J, Vénuat A-M, DaSilva J, Duverger A, Duarte N, Hartmann O, Spengler BA, and Bernheim A (1999). Phenotypic and genotypic diversity of human neuroblastoma studies in three IGR cell line models derived from bone marrow metastases. Cancer Genet Cytogenet 112, 124-129.
12. Mora J, Cheung N-KV, Juan G, Illei P, Cheung I, Akram M, Chi S, Ladanyi M, Cordon-Cardo C, and Gerald WL (2001). Neuroblastic and Schwannian stroma cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res 61, 6892-6898.
13. Spengler BA, Walton JD, Biedler JL, Mora J, Gerald WL, Cheung N-KV, and Ross RA (2002). Highly malignant human neuroblastoma I-type stem cells are components of human neuroblastoma tumors as well as cell lines. Proc Am Assoc Cancer Res 43, 1014.
14. Reynolds CP, Tomayko MM, Donner L, Helson L, Seeger RC, Triche TJ, and Brodeur GM (1988). Biological classification of cell lines derived from human extracranial neural tumors. In Evans AE, D'Angio GJ, Knudson AG, Seeger RC (Eds.), Advances in Neuroblastoma Research 2, pp. 291-306 Alan R. Liss, Inc., New York, NY.
15. Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, and Reynolds CP (1993). Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer 72, 3346-3354.
16. Spengler BA, Domènech C, Porubcin M, and Biedler JL (1994). Human neuroblastoma lines respond differently to diverse differentiation-inducing agents. In Evans AE, Brodeur G, Biedler JL, Nakagawara A (Eds.), Advances in Neuroblastoma Research 4, pp. 261-268 Wiley-Liss, New York, NY.
17. Ikegaki N, Bukovsky J, and Kennett RH (1986). Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc Natl Acad Sci USA 83, 5929-5933.
18. Lazarova DL, Spengler BA, Biedler JL, and Ross RA (1999). HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts. Oncogene 18, 2703-2710.
19. Nikolopoulos SN, Spengler BA, Kisselbach K, Evans AE, Biedler JL, and Ross RA (2000). The human non-muscle α-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 19, 380-386.
20. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, and McEwan RN (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47, 3239-3245.
21. Thomas SK, Messam CA, Spengler BA, Biedler JL, and Ross RA (2003). Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279, 27994-27999.
22. Wognum AW, Eaves AC, and Thomas TE (2003). Identification and isolation of hematopoietic stem cells. Arch Med Res 34, 461-475.
23. Luo R, Gao J, Wehrle-Haller B, and Henion PD (2003). Molecular identification of distinct neurogenic and melanogenic neural crest sublineages. Development 130, 321-330.
24. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, and Weissman IL (2000). Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97, 14720-14725.
25. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, and Kornblum HI (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100, 15178-15183.
26. Whitesell L, Rosolen A, and Neckers LM (1991). Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines. Mol Cell Biol 11, 1360-1371.
27. Lutz W, Stohr M, Schurmann J, Wenzel A, Lohr A, and Schwab M (1996). Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 13, 803-812.